Lamb Weston remains a Buy, with turnaround efforts and cost-saving initiatives supporting a compelling valuation despite macro headwinds. LW's Q3 FY26 results saw volume gains once again offsetting price declines while also boosting FY26 net sales and EBITDA guidance. Significant CAPEX reductions and a $250 million cost-saving plan are expected to boost free cash flow and support long-term growth.